技术指标
指标
数值
方向
MACD(12,26,9)
-0.022
卖出
RSI(14)
32.676
中性
STOCH(KDJ)(9,3,3)
20.459
买入
ATR(14)
0.047
高波动
CCI(14)
-80.530
中性
Williams %R
82.170
超卖
TRIX(12,20)
-1.294
卖出
StochRSI(14)
100.000
买入
搜索
cbdMD Inc
YCBD添加自选
0.509USD
+0.038+8.05%
收盘 07-31 16:00（美东）报价延迟15分钟
5.12M总市值
0.02市盈率 TTM
关键数据
0.490今开
0.534最高
161.43K成交量
0.02市盈率 TTM
亏损市盈率动
--股息TTM
1.60%换手率
0.471昨收
0.480最低
60.64K成交额
亏损市盈率静
0.57市净率
0.00%股息率 TTM
-22.91%ROA
2.56052周最高
0.72量比
-7.70M净利润
10.07M总股本
28.1293每股收益TTM
2.15Beta
-62.55%ROE
0.47052周最低
11.49%振幅
53.29%毛利率
5.12M总市值
-3.53回报/风险
8.85%风险率
TradingKey cbdMD Inc股票评分
单位: USD 更新时间: 2026-07-31操作建议
cbdMD Inc当前公司基本面数据相对健康，增长潜力很大。当前估值合理，在药品行业排名68/155位。机构持股占比非常高，近一月多位分析师给出公司评级为买入。最高目标价2.00。中期看，股价处于下降通道。近一个月，市场表现非常差，但基本面评分较高。目前股价在压力位和支撑位之间，可以做区间波段操作。
cbdMD Inc评分
压力支撑
由于公司未披露，未能获取相关数据
多维评测
本期评分
上期评分
公司舆情
过去24小时
热度
过冷
过热
看好
cbdMD Inc亮点
亮点风险
cbdMD, Inc. is a cannabidiol (CBD) company. The Company has a comprehensive line of United States produced, THC-free CBD products, including NSF Certified for Sport products, as well as its new Full Spectrum products. The Company's flagship brands include cbdMD and Paw CBD, as well as its functional mushroom brand ATRx Labs. Its cbdMD brand includes high-grade, premium CBD products including CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD sleep aids and CBD drink products including its Herbal Oasis Social Tonic and an array of Farm Act compliant Delta 9 products. Its Paw CBD brand of pet products includes veterinarian-formulated products including tinctures, chews, topicals products in varying strengths, and its ATRx brand of natural functional mushroom support. Its cbdMD, Paw CBD and ATRx products are distributed through its e-commerce websites, third party e-commerce sites, select distributors and marketing partners as well as a variety of brick-and-mortar retailers.
业绩增长期
公司处于发展阶段，最新年度总收入19.19M美元
估值高估
公司最新PE估值0.02，处于3年历史高位
分析师目标
根据
1
位分析师
买入
评级
2.000
目标均价
+309.00%
涨幅空间
cbdMD Inc新闻
即将为您带来更多新闻，敬请期待。。。
收益预测
分析师评级
根据
1
位分析师
买入
评级
2.000
目标均价
+309.00%
涨幅空间
强力买入
买入
持有
卖出
强力卖出
同行比较
160
总数
6
中位数
9
平均值
公司名称
评级分布
分析师数
cbdMD Inc
YCBD
1
Biogen Inc
BIIB
38
安进
AMGN
38
礼来
LLY
34
艾伯维
ABBV
33
辉瑞
PFE
32
1
2
3
...
32
技术指标
移动平均线
指标
数值
方向
MA5
0.497
买入
MA10
0.532
卖出
MA20
0.614
卖出
MA50
0.677
卖出
MA100
0.731
卖出
MA200
0.832
卖出
财务指标
每股收益
由于公司未披露，未能获取相关数据
营业总收入
由于公司未披露，未能获取相关数据
cbdMD Inc简介
cbdMD, Inc. is a cannabidiol (CBD) company. The Company has a comprehensive line of United States produced, THC-free CBD products, including NSF Certified for Sport products, as well as its new Full Spectrum products. The Company's flagship brands include cbdMD and Paw CBD, as well as its functional mushroom brand ATRx Labs. Its cbdMD brand includes high-grade, premium CBD products including CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD sleep aids and CBD drink products including its Herbal Oasis Social Tonic and an array of Farm Act compliant Delta 9 products. Its Paw CBD brand of pet products includes veterinarian-formulated products including tinctures, chews, topicals products in varying strengths, and its ATRx brand of natural functional mushroom support. Its cbdMD, Paw CBD and ATRx products are distributed through its e-commerce websites, third party e-commerce sites, select distributors and marketing partners as well as a variety of brick-and-mortar retailers.
公司代码YCBD
公司cbdMD Inc
CEOKennedy (T. Ronan)
网址https://www.cbdmd.com/
公司股东
相关品种
热门品种
常见问题
cbdMD Inc(YCBD)的当前股价是多少？
cbdMD Inc(YCBD)的当前股价是 0.51。
cbdMD Inc的股票代码是什么？
cbdMD Inc的股票代码是YCBD。
cbdMD Inc股票的52周最高点是多少？
cbdMD Inc股票的52周最高点是2.56。
cbdMD Inc股票的52周最低点是多少？
cbdMD Inc股票的52周最低点是0.47。
cbdMD Inc的市值是多少？
cbdMD Inc的市值是5.12M。
现在cbdMD Inc(YCBD)的股票是买入、持有还是卖出？
根据分析师评级，cbdMD Inc(YCBD)的总体评级为买入，目标价格为2.00。
cbdMD Inc(YCBD)股票的每股收益（EPS TTM）是多少
cbdMD Inc(YCBD)股票的每股收益（EPS TTM）是-1.09。